Vol. 7 No. 5 (2025)

Published December 19, 2025

Brazilian Journal of Health and Pharmacy

Full Issue

PDF (Português (Brasil))

Editorial Letter

Tiago Marques do Reis

Ini2

Progress, consolidation, and prospects for a new cycle.

https://doi.org/10.29327/226760.7.5-1

PDF (Português (Brasil))

DOI: https://doi.org/10.29327/226760.7.5-1

Articles

Samara de Fátima Miranda, Daniel Silva Sena Bastos, Adriane Jane Franco, Emília Torres Costa Marques

05-15

Profile of the most requested compounded formulations and user perceptions at a compounding pharmacy in Viçosa, Minas Gerais, Brazil

https://doi.org/10.29327/226760.7.5-4.

PDF (ingles) (Português (Brasil))

DOI: https://doi.org/10.29327/226760.7.5-4.

16-26

Clinical, demographic, and histopathological profile of drug-induced cutaneous reactions in a Mexican tertiary hospital: a nine-year retrospective study

https://doi.org/10.29327/226760.7.5-3

PDF (ingles)

DOI: https://doi.org/10.29327/226760.7.5-3

Amanda Atanielly Ribeiro, Paulo Sérgio Gonçalves de Alcantara, Rafael Márcio dos Santos Souza, Edmar Rocha Almeida

27-41

Acetylsalicylic acid in the prevention of cardiovascular events: patients’s profile in a city in Minas Gerais

https://doi.org/10.29327/226760.7.5-4

PDF (Português (Brasil))

DOI: https://doi.org/10.29327/226760.7.5-4

Maria Ruth Silva Ribeiro, Karina Marjorie Silva Herrera, David Extanislei Rosa, Camila Eustáquio Sales, Bárbara Macedo Kuchenbecker, Magna Cristina de Paiva

42-55

Evaluation of the susceptibility of Escherichia coli to first-line antimicrobials for the treatment of urinary tract infection

https://doi.org/10.29327/226760.7.5-5

PDF (Português (Brasil))

DOI: https://doi.org/10.29327/226760.7.5-5